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Abstract: Background: Despite the advances in End-of-life (EOL) cancer care, disparities remain in
the accessibility and utilisation of EOL cancer care resources. Often explained by socio-demographic
factors, geographic variation exists in the availability and provision of EOL cancer care services
among EOL cancer decedents across urban versus rural settings. This systematic review aims to
synthesise mortality follow-back studies on the patterns of EOL cancer care resource use for adults
(>18 years) during end-of-life cancer care. Methods: Five databases were searched and data analysed
using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Inclusion
criteria involved; (a) original research; (b) quantitative studies; (c) English language; (d) palliative care
related service use in adults (>18 years) with any malignancy excluding non-melanoma skin cancers;
(e) exclusive end of life focus; (f) urban-rural focus. Narrative reviews and discussions were excluded.
Results: 24 studies met the inclusion criteria. End-of-life cancer care service utilisation patterns varied
by rurality and treatment intent. Rurality was strongly associated with higher rates of Emergency
Department (ED) visits and hospitalisations and lower rates of hospice care. The largest inequities
between urban and rural health service utilisation patterns were explained by individual level factors
including age, gender, proximity to service and survival time from cancer diagnosis. Conclusions:
Rurality is an important predictor for poorer outcomes in end-of-life cancer care. Findings suggest
that addressing the disparities in the urban-rural continuum is critical for efficient and equitable
palliative cancer care. Further research is needed to understand barriers to service access and usage
to achieve optimal EOL care for all cancer patient populations.
Keywords: end-of-life care; palliative care; cancer care; urban-rural; healthcare service
1. Introduction
Background
Worldwide, the demand for end-of-life (EOL) care is growing with the global estimated number
of adults in need of EOL care over 19 million [1]. The majority of this demand is due to the increasing
prevalence of serious illnesses such as cancer [2]. EOL care continues to provide significant benefits
to cancer decedents from relieving symptoms and pain, improving quality of life, and in some cases,
survival [3]. Despite these benefits, disparities remain in access to and utilisation of EOL cancer
care resources often influenced by a variety of factors from government investment, service delivery
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practices and socio-demographic factors, particularly among those in rural communities compared
with urban areas [4].
Several pervasive social and structural factors have been identified as being important determinants
of the patterns of EOL cancer care including barriers at the patient, physician and healthcare system
level [5]. Previous research has shown that geographic variation exists in the availability and provision
of EOL cancer care services within and between countries [6], particularly among vulnerable groups
including the elderly and cancer decedents living in rural settings. Access to such care for rural and
remote patients and carers has been identified as an area in particular need of focused research [7].
Geographic remoteness or rurality in the health context is defined as living outside of places with
population densities of 400 or more per square kilometre [8]. This is of primary interest, given the extent
of inequities indicating rurality to be a strong predictor of high utilisation rates of EOL acute-care [9–13]
and community based care services [13,14] and disproportionately low access and underutilisation of
palliative care services [15–18].
The underlying reasons why EOL cancer care is often disproportionately underutilised, provided
ineffectively or not provided at all among patients residing in rural and regional areas [19] is complex
and often explained by socioeconomic and geographical factors such as resource and funding restraints
in rural areas [20]. Previous reviews have highlighted EOL care to be an essential service in rural
communities, yet the literature also suggests there is a relationship between rurality and poorer quality
of EOL care [21]. Given the complexity in defining rurality, there remains a clear need to examine
the influence of rurality and patterns of healthcare service utilisation by EOL cancer patients [21].
After a thorough examination of all past and relevant reviews, including those in the Cochrane
Library database, it is clear that no study has systematically reviewed the literature that examined the
association between rurality, in particular urban versus rural region of residence, and the utilisation
patterns of healthcare services in EOL cancer decedents.
Providing equitable EOL healthcare to individuals, irrespective of their region of residence
presents as a significant challenge to healthcare systems worldwide. Exploring the types and patterns
of healthcare services used among underserved populations such as rural residents during their last
months of life is crucial to understanding the quality and appropriateness of care provided. Research
using secondary health administrative data can provide crucial insight into the treatment patterns of
urban and rural residents enduring EOL cancer care. The findings uncovered by these large datasets
have the potential to inform policies that are tailored to addressing the barriers faced by vulnerable
populations such as rural residents in order to respond to the challenge by enabling universal access to
quality EOL cancer care [2]. This systematic review provides a clear outline of the methodology used
to find relevant studies exploring rurality and EOL cancer care along with a comprehensive analysis of
the interplay between these factors in the results and discussion sections.
In addition to the strong evidence on the benefits of EOL cancer care in relieving symptoms
and pain, improving quality of life, and in some cases, survival (3), there is also evidence that
high quality palliative care could lead to reduced hospitalisations and emergency department (ED)
presentations [22]. The challenge lies in ensuring equity in the delivery of EOL cancer care across all
populations, particularly those living in rural and remote areas where limited resourcing, across a large
geographic area with decreased population density remains a key factor. The aim of this systematic
review is to synthesise mortality follow-back studies on the influence of rurality on the patterns of
EOL cancer care service use in decedents with cancer.
2. Materials and Methods
2.1. Selection Protocol
The systematic review followed the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses guidelines [23]. Study identification and selection process is displayed in Figure 1.
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Search protocol was independently conducted by the authors with predefined search terms and
strategies from databases of published peer-reviewed literature.
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Figure 1. Flowchart of publications included in the systematic review.
2.2. Search Strategy
A search was conducted in Medline, The Cumulative Index to Nursing and Allied Health
Literature (CINAHL), PubMed, Scopus and Web of Science using keywords “healthcare” OR “health
service” OR “hospitalization” OR “health service utilization” AND “cancer” OR “neoplasm” OR
“malignant” OR “carcinoma” OR “palliative care” OR “end of life care” OR “terminal care” AND
“rural” OR “remote”. No limits applied. Reference lists were scanned to ensure all related publications
were included (Supplementary Table S1).
2.3. Inclusion/Exclusion Criteria
Studies reporting on health service utilisation at end-of-life occurring during any defined period
were included. Articles without a definition of rurality and/or a comparison group (rural versus urban)
were excluded. Inclusion criteria included original articles examining urban versus rural residence
(e.g., rurality, geographic remoteness, urbanisation, region of residence) of relevance to at least one
end-of-life palliative care service utilisation related outcome in adult cancer patients (≥18 years),
published post-1990 in the English language. Exclusion criteria included reviews to minimise the
risk of including the same studies more than once, discussions and any other non-original articles
(Supplementary Table S2).
2.4. Data Extraction and Analysis
Relevant data were extracted using a customised Microsoft Excel spreadsheet adapted from the
Cochrane Systematic review template [24]. With a random sample selected, all authors’ cross-checked
extracted data and any disagreements that arose were resolved through discussion and further analysis.
Int. J. Environ. Res. Public Health 2020, 17, 4955 4 of 15
Study quality and risk of bias was assessed using the protocol developed by Dzhambov et al. [25] and
the 1.0 point checklist from the National Heart Lung and Blood Institute (NHLBI) Quality Assessment
Tool for Observational Cohort and Cross-sectional Studies [26]. Based on a set of 14 criteria, a quality
rating was agreed upon by the authors using a score of Yes = 1, No = 0, Cannot Determine = 0 in
response to each question. Answers of Not applicable = 0 were excluded from the total applicable
count. A quality score was calculated as a percentage calculation of (total positive/total applicable) and
classified as: <0.50 (low quality), 0.50–0.74 (fair quality) and 0.75–1.00 (high quality). Results were
discussed and any discrepancies were resolved by the authors. The checklist included 14 questions
with 12 applicable to observational mortality follow-up study designs (Supplementary Table S3).
The criteria assessed the research question, study population, population eligibility criteria, sample
size justification, exposure measures and assessment, study timeframe, outcome measures, follow-up
rate and statistical analyses.
Owing to clinical and methodological heterogeneity of identified studies it was not possible to
conduct a meta-analysis, thus, a narrative synthesis of quantitative results was conducted. The key study
characteristics of the included studies are summarised, including the results in (Supplementary Table S4).
3. Results
In total, 816 studies were identified through five databases using selected search terms
(Supplementary Table S1). Of these, 653 studies were removed based on title and abstract review with
193 being duplicates (Figure 1). From the remaining 163 studies, 144 studies were excluded after full
text review as they did not compare urban versus rural outcomes. An additional five studies were
identified and included through cited references and google scholar searches.
3.1. Characteristics of Included Studies
Twenty-four studies were included in the review (n = 100%). All studies employed quantitative
methodologies linking pre-existing secondary data to area-level specific residential geography
classification data. All studies used retrospective mortality follow-back study designs. The majority of
the articles were published in the last decade (58%) and represented health databases of populations in
Canada (38%), USA (38%), Taiwan (13%), Australia (8%) and Germany (3%).
3.2. End-of-Life Period Classification
All studies measured a defined end-of-life period that ranged from 2 weeks to 18 months before
death. Eighteen studies (75%) classified the end-of-life period as less than the last 12 months of life.
Three studies (13%) included a shorter time period, that is, the last 2 weeks of life [9,17,27] (Table 1,
Supplementary Table S3).
Table 1. Overview of included studies (n = 24).
Study Characteristic Group Number of Studies i
Year of publication
1998–2004 4
2005–2012 10
2013–2019 10
Study setting (country)
Canada 9
USA 9
Taiwan 3
Australia 2
Germany 1
Study design
Case Control study (CCS) 1
Cross-sectional study (CSS) 2
Cohort/Longitudinal study (CS) 21
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Table 1. Cont.
Study Characteristic Group Number of Studies i
Statistical analysis methods
Linear Regression 5
Univariate logistic regression 3
Binary logistic regression 4
Multivariate logistic regression 15
Negative binomial regression 1
Hierarchical non-linear regression 1
Cos proportional hazards regression 1
Poisson Regression 1
No comprehensive analysis
techniques used 1
Quality assessment iii
High 14
Fair 7
Low 3
Inclusion criteria (minimum age)
Any age 6
18–20 9
65–70 7
Not Reported 2
End-of-life period
≤1 month 9
6 months 3
9 months 1
12 months 4
>12 months 1
Variable ii 2
Not Reported 4
Cancer types
Lung 15
Colorectal 14
Prostate 12
Breast 11
Haematological 9
Gynaecological 4
Pancreatic 4
Head and Neck 4
Upper gastrointestinal 4
Liver 4
Melanoma 2
Central Nervous System 2
Healthcare services
Chemotherapy 7
ED/ER visit 10
Hospital admission 8
ICU admission 6
SPC service/s 15
Palliative Radiotherapy 2
Home doctor/physician visit/s 3
Prescription medication/s 1
Note: i—includes a cumulative count reflective of studies assessing multiple outcome variables; ii—study quality
was assessed using the Quality Assessment Tool for Observational Cohort and Cross-sectional Studies [26],
ED—Emergency department; ER—Emergency Room; ICU—Intensive Care Unit, SPC—Specialist Palliative Care,
iii—variable EOL period including time from an event or treatment with palliative intent until death, such as
palliative radiotherapy, hospice enrolment/use.
3.3. Urban Versus Rural classification
Studies that compared findings from both urban and rural populations were of primary interest.
Twenty definitions and measures of rurality were used across the studies (Supplementary Table S5).
These included derivations of “region of residency” defining rural areas as communities with
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populations <10,000 people [28], urban areas as regions with a population density of >400 persons
per km2 [10] and both rural and urban areas were defined as a non-metropolitan and metropolitan
county [17], respectively. A range of global databases were used to measure each exposure variable
including: postal code data, Surveillance, Epidemiology and End Results Medicare data registry (SEER)
database and Accessibility Remoteness Index of Australia (ARIA) database classifications. The most
common index used to measure rurality was objective measures of population concentration derived
from 2006 Canadian Census of the Populations and the Registered Persons Database (RPD). This was
assessed in four studies (17%) [9,11,28,29].
3.4. Cancer Classification and Tumour Characteristics
Cancer diagnoses were categorised according to the International Classification of Disease (ICD)
codes (n = 19), SEER [17,18] (n = 2) and the Cancer Agency Information System (CAIS) [30] (n = 1).
Cancer diagnoses were identified using administrative health database claims (n = 11), cancer registries
(n = 10), death certificates [31] (n = 1), health insurance claims [32] (n = 1), palliative program enrolment
records [33] (n = 1) and linked cancer registry and death certificate data [34] (n = 1). Using the ICD
classification codes, 13 types of cancer were assessed (Table 1) with the most common being lung (n = 15)
and colorectal (n = 14). The stage of tumour at diagnosis was assessed in five studies [12,14,17,18,35]
using two classification systems; the historic staging system collected using SEER data and the
American Joint Committee on Cancer classification system [18]. Studies that assessed the stage of
tumour at diagnosis included stages I–IV specific to colorectal cancer [35], stages III–IV specific to
advanced breast cancer [17] and stages I–IV specific to lung and colorectal cancer [18].
3.5. Healthcare Service Utilisation—Treatment Intent
Nine types of healthcare services were included (Table 1) that reflect three classifications of
treatment intent. Life-sustaining treatment includes chemotherapy (n = 7), ED visit/s (n = 10), hospital
admission/s (n = 8) and Intensive Care Unit (ICU) admission/s (n = 6). Community-based care includes
home health, home doctor, physician and general practitioner (GP) visit/s (n = 3). Palliative care
includes specialist palliative care (SPC) services (n = 2) inclusive of hospice services (n = 10), palliative
radiotherapy (PRT) (n = 2) and pharmacotherapy (n = 1).
3.6. Study Quality
Using the 1.0 point checklist from the NHLBI Quality Assessment Tool for Observational Cohort
and Cross-sectional Studies [26], two (8%) studies were deemed high quality having justified sample
size, power descriptions or variance and effect estimates. Eighteen studies (75%) were deemed
fair quality with many using a pre-specified and uniformly applied inclusion and exclusion criteria
and sufficient study timeframe. Four studies (17%) were deemed low quality due to the lack of
comprehensive statistical analysis or measurement and adjustment for confounding factors.
3.7. Results by Primary Outcome
3.7.1. Urban-Rural Effect on Acute and Life-Sustaining Healthcare Services Use
Seven studies assessed the utilisation of chemotherapy [9,11–13,29,35,36], 10 studies assessed the
number of ED visits [9–12,27–29,33,35,36], eight assessed hospital admissions [11–13,15,29,35,36] and
six studies assessed the number of ICU admissions [9,11,12,29,35,36] in relation to rurality (Table 1).
Among entire death cohorts who received chemotherapy in the last 14 days of life in a hospital setting,
irrespective of rurality, the rates of chemotherapy usage varied from 2–4.5%. When assessed as an
independent variable and in relation to rurality, four studies found no difference in the odds of receiving
chemotherapy in the last 14 days of life according to rural region of residency (p > 0.05) [9,13,29,35].
The rates of ED visits, irrespective of rurality, also varied considerably from 27–60% of death
cohorts depending on the period in which as least one ED visit was recorded across a three-year
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study period, the last six months of life and the last 30 or 14 days of life. When assessed over a
three-year study period, one study concluded 0.76 lower ED visits (95% CI, 0.23–2.36) among residents
in urban areas than rural even after controlling for out-of-hours periods of palliative care home care [33].
When assessed over the last six months of life, one study found rural region of residence increased the
odds of having at least one ED visit, with 5% spending more than 30 days in hospital (OR 1.25, 95% CI,
0.2–1.90) [28]. Another study also found rural residency to increase the rate ratio of the total number of
ED visits after controlling for patient characteristics and the effect of continuity of care with a family
physician (OR 1.29, 95% CI, 1.21–1.37) [10]. Similar results were found in four studies where higher
rates of ED visits were reported in the last 30 days of life [29,35] among cancer decedents living in
rural areas compared to urban areas with rates reducing with narrower time periods to death [35] such
as the last two weeks of life [9,27].
The rates of more than one hospital admission varied from 8.5–85.4% of death cohorts in their last
30 days [29] and last year of life [16], respectively, significantly reducing with narrower time periods
to death. In the last three years prior to death, two studies found decedents with a rural geographic
region of residence to have an increased likelihood of having at least one hospital admission [15,16].
Similarly, over the last 30 days of life, two studies also found rural region of residence to have a strong
association with multiple hospitalisations [29,35] with Hu et al. [35] reporting cancer decedents of
Calgary (rural region) as having 3.3–5.3 times the adjusted odds of being hospitalised more than once.
Additionally, Walter et al. [13] found the likelihood of having more than 14 hospital days in the last
30 days of life to be significantly higher for decedents in rural districts than in remote rural districts
(1.27 (1.05, 1.52), p = 0.0003).
Three studies examined ICU admissions as a primary outcome. When assessed over the last
2 weeks of life, Hu et al. [35] found the rate of ICU visits among cancer patients in Ontario to be 5.4%
of the cohort and rurality to be significantly associated with ICU admissions. When assessed over the
last 30 days of life, this rate increased to 7.2% [29]. One study found rural region of residence to be
strongly associated with an increase in ICU admissions (1.91 (0.77–4.73), p > 0.05) among colorectal
cancer patients in Alberta. However, in contrast, Conlon et al. [29] were unable to find similar evidence,
finding no association between rural locations and the odds of receiving intensive care in the last 30 days
among a cohort of Ontario cancer patients. In multivariable analyses, when the use of chemotherapy,
ED visits, hospital and ICU admissions were assessed in a composite measure of aggressive EOL care,
three studies found decedents were more likely to receive aggressive EOL care if they resided in rural
regions compared to those in urban or metropolitan areas [11,12,36].
3.7.2. Urban–Rural Effect on Community-Based Healthcare Services Use
Three studies explored the association between rurality and GP visits [13] and home doctor
services [15,16] (Table 1). In a cohort of lung cancer patients, the number of visits to the GP (physician)
in the last 30 days of life was significantly lower in urban districts than in remote rural districts
(β = −0.19 (−0.32, −0.06), p = <0.0001) [13]. Similar results were also found in a data linkage study
of palliative colorectal and lung cancer patients in the United States where those living in a rural
geographic region were slightly more likely to use home health services (1.19 (1.02–1.39)) than those in
urban regions [15].
3.7.3. Urban-Rural Effect on Palliative Healthcare Services Use
As measures of specialist palliative care two studies examined SPC usage [31,37], 10 studies
examined the use of hospice care [12,14–18,32,38–40], two studies assessed receipt of PRT [30,34] and
one study assessed receipt of pharmacotherapy [13] (Table 1). Regarding SPC usage, Burge et al. [37]
found residents in rural regions compared with urban were less likely to be registered with a palliative
care program (PCP) after controlling for age (0.8 (0.7–1.0)). Likewise, Rosenwax and McNamara [31]
also found a disproportionate distribution of SPC usage by rurality finding cancer decedents were
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significantly less likely to receive SPC in the last 12 months of life if they lived in a region other than a
major city.
The rates of hospice enrolment and utilisation, irrespective of rurality, varied considerably across
the studies from 7% enrolment at more than 180 days before death [18] to 63% of the death cohort enrolled
more than 7 days before death [38]. Despite an increasing trend of hospice demand and use in rural areas
over the study periods in two studies [14,32], a consistent finding was that the odds of hospice enrolment
was lower for patients residing in a rural area than an urban or metropolitan region [14–18,32,38–40].
Additionally, when assessed as a composite measure of potentially aggressive EOL care within the last
30 days, including (chemotherapy received within 14 days of death, >1 emergency department (ED)
visit within 30 days of death, >1 hospitalisation within 30 days of death, ≥1 intensive care unit (ICU)
admission within 30 days of death, in-hospital death and hospice enrolment ≤3 days before death)
decedents who resided in non-metropolitan areas were more likely to have aggressive care including
late and short hospice enrolment (less than 3 days before death) [12].
Assessed in just two studies, the patterns of PRT treatment rates were observed to be low,
geographically-dependent and vary from 14% at any point after prostate cancer diagnosis [30] to
22.5% in the last 9 months of life in decedents with lung, breast, melanoma and prostate cancer [34].
Soo et al. [30] found more remote regions to have lower PRT utilisation rates and decedents who resided
in areas that were geographically removed from a cancer centre were less likely to receive PRT. Similarly,
Lavergne et al. [34] also found, through univariate analysis that living in a rural area was a predictor of
lower rates of PRT consultation and treatment. In a multivariate analysis however, rural residence
was no longer significant due to collinearity with travel time and deprivation [34]. Just one study
examined the urban-rural differences in EOL patterns of pharmacotherapy with antidepressants and
pain relief medication [13]. Examining the receipt of pharmacotherapy treatment with antidepressants
and structured pain relief during the last 30 days of life, Walter et al. [13] were unable to find any
regional differences in pharmacotherapy treatment patterns.
The interpretation of these findings is challenging because of the heterogeneity of methodologies,
classification of study periods and rurality. It seems clear, however, that decedents residing in rural
or remote areas had higher odds of receiving more acute-aggressive care and community-based
care and lower odds of receiving palliative care including SPC services such as hospice and
palliative radiotherapy.
3.7.4. Covariate Effect
Twenty-two studies assessed effect estimates of individual and geographical area level covariates
including age, gender, marital status, insurance, cancer diagnosis and stage and distance to health
service (Table 1). Specific to the use of acute and life-sustaining healthcare services, being younger
(<60 years), having breast, lung, or hematologic malignancies, having a rural postcode, having two
or more comorbidities or being male was prognostic for greater odds of an ED visit or death in
acute care [11,28]. Having a follow-up visit with an oncologist was also associated with multiple
hospitalisations in the last 30 days of life [35]. Being aged (<50 years), male and with a rural region of
residence was associated with lower rates of ICU admissions in the last 30 days of life [9,29]. Patients
with breast cancer were 88% more likely to receive chemotherapy in the last two weeks of life than
patients with colorectal cancer (p < 0.001) [11].
The effects of covariates on service usage with community-based care intent, including comorbidities
at time of diagnosis (e.g., congestive heart failure, chronic obstructive pulmonary disease) were found
to be significantly associated with a lower number of doctor visits [13]. In relation to palliative care
services, the location and supply of hospices were found to play a major role in hospice utilisation
rates in rural areas [32]. Distance to the closest cancer centre was an important factor in Palliative
Care Programs (PCP) use where individuals aged 85 years and over were 17 times more likely to
be registered with a PCP if they lived 10 km or less from the cancer centre compared with those
who lived over 50 km away [37]. Increasing household income [38], increasing age (65+ years) [17],
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not married [18,31], being male [18] and having fee-for-service insurance [18] were indicative of lower
odds of receiving hospice care and SPC services. PRT treatment rates in the last nine months of
life also varied by age and region of residence and declined with increasing travel time to nearest
PRT centre [34].
4. Discussion
This systematic review of retrospective mortality follow-back design studies provides evidence of
higher odds of EOL cancer care acute-care service usage and underutilisation of palliative services
with greater geographic remoteness. Limited evidence was found for the influence of geographic
remoteness on the use of EOL cancer care community-based services.
Evidence on the influence rurality has on the EOL cancer care among adults has grown over
the past decade with the majority of studies coming from a select group of high-income countries.
Although heterogeneous in nature, the findings across the studies are markedly similar, that is, finding
substantial geographical variation in EOL cancer care. The resource utilisation patterns detailed in
this review have important implications particularly for identifying areas in need of further research
such as studying patient demographics as predictors of palliative and hospice service utilisation and
assessing the appropriateness, timeliness and quality of EOL cancer care by treatment intent with a
focus in the rural setting.
4.1. Relevance to Prior Knowledge
Unsurprisingly, the majority of the findings of this review remain consistent with the findings of
prior reviews where authors also reported an inverse relationship between EOL resource use and age
and a consistent trend of underutilisation of palliative services among rural EOL cancer decedents [41].
Past reviews that focussed on healthcare provider and patient barriers and quality of EOL care also
identified low provider comfort, limited scope of practice [42] as well as family member’s avoidance
issues around dying [43] as being distinct challenges faced by rural communities when it comes to
EOL cancer care. From an ecological perspective, this systematic review remains the first to provide
additional insight into the influence geographical remoteness has on the patterns of EOL cancer
care among patient populations residing in rural and urban locations. With significant variations by
geographic remoteness and treatment intent, the patterns of EOL cancer care among rural decedents
reflected an over reliance on acute-care services including ED visits [9,10] and hospital admissions in
the last 30 days before death [11–13] and an underutilisation of palliative services such as hospice care
in the last 12 months of life [14,18,31,32,38,40].
Theresultsof thisreviewalsohighlight the influenceconfoundingfactorshaveinthepatternsofEOLcancer
care utilisation, namely age [9–18] and gender [2–40], cancer characteristics (stage of diagnosis [17,18,35,40],
cancer type [9–18,27–40], survival time [10,11,13,15,16,29,34–37,39], comorbidities [9,11,13–17,28,35] and
distance to nearest cancer centre [37]. The interplay of these factors is complex as many communities and
individuals have overlapping characteristics [37]. This review highlights the current evidence gap that
remains in quantifying the theorised pathways of mediation and effect modification to better explain
the variation in EOL cancer care provision. Recent research suggests that whilst there is no simple
explanation for the growing inequity in EOL cancer care provision across urban-rural populations,
referral patterns to specialist palliative care, proximity to services [44], including travel time and
road network factors, and socio-economic status may be additional confounding factors worthy of
further investigation.
Consistent with the findings of this systematic review, Gao et al. [45] found living more than
30 kilometres from a PCP was associated with lower PCP enrolment. A lack of resources to refer to
and reluctance to refer in rural areas is also one of a few reasons postulated by researchers such as
Hawley [46] to explain the disparities seen in EOL cancer care across urban and rural settings. Ensuring
future studies simultaneously adjust for multiple demographic, health service and socio-cultural
indicators will help to provide greater insight into understanding the important determinants of the
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patterns of EOL cancer care and reviewing public health policies to ensure equity in the distribution
and usage of palliative care services.
With the concept of ‘rurality’ having been widely acknowledged in public health policy making
and resource allocation [47], a variety of quantitative and qualitative methods have been proposed to
define ‘rurality’ for various purposes. These measures are based largely on classifications related to
geography, including administrative units such as counties, census tracts or postal-code areas [48].
Across the included studies, 20 different definitions and measures of ‘rurality’ were used, highlighting
a high degree of heterogeneity brought about by a lack of standardised metrics to clearly define and
measure ‘rurality’ in the context of assessing EOL cancer care on a global scale.
Researchers examining health service access have acknowledged the limitations associated with
oversimplifying the definition of ‘rurality’ where significant cultural, demographic and socioeconomic
characteristics are commonly overlooked [49]. Nonetheless, throughout the identified studies,
definitions that measured both population density and used zip codes to measure distance to urban
regions appeared to be a more valid measure of rurality [9,28,29,37]. These criteria attempt to designate
‘rural’ areas beyond a geographic boundary considering other factors such as access to health services
and supply of oncology and palliative care services, where the supply of these services is commonly
influenced by population demographics [50]. The use of standardised composite indexes to define
and measure rurality may be beneficial in future rural health research. Solely focussing public health
programs to improve EOL cancer care provision in rural areas on geographic boundary evidence
may hinder their effectiveness by diverting attention away from other more fundamental social and
structural processes.
Furthermore, eight types of EOL cancer care services were examined in the context of five countries
across the studies. Firstly, it is important to note the effects of differing health systems according to the
country referred to in the cited studies. According to the country of the studies, one notable difference
in the findings was identified in the study by Walter et al. [13], where receipt of antidepressants and
pain relief medication were not associated with geographical or regional differences. Noting that this
outcome was assessed in just one study, the authors state that regional differences in EOL care are
not an issue in a German setting as EOL care providers such as GPs and hospice services are found
in every district type [13]. It is therefore plausible that the nature of the healthcare system in their
governance, overall design and function, vastness of the geography and cultural ideologies of different
countries may be influencing the types of services used, timing of receipt of quality care and patient
preferences. Examined in just three studies, our results also indicate that healthcare supply factors
such as hospice supply, bed supply and SNF supply may not play as much of an important role in EOL
cancer care as location of services. Future research is needed to examine this relationship and others
including palliative care delivery programs in other settings.
4.2. Strengths and Limitations
The study generated important insights about the impact of rurality on healthcare service
utilisation at EOL in people with cancer. The strengths of the study include the comprehensive database
search, rigorous quality assessment and assessment of multiple outcome measures covering services
with acute care and life sustaining care, community-based care and palliative care intent.
Limitations include the language restrictions of the database search strategy, excluding non-English
articles, and thus, potentially resulting in an underrepresentation of research from non-English
speaking countries. The issue of residential self-selection across urban and rural geographies may
make inferences regarding causality more difficult as patterns of EOL cancer care utilisation based
on individual behaviours may appear as an inflated geographic related effect. The methodology of
grouping acute-care health services could be problematic, given that for some rural settings it is possible
that this represents one of only a few options to get healthcare, especially after-hours. The study
results could be influenced from reverse causation bias if these factors are overlooked. The variation in
sample sizes and design of the studies and incomplete adjustment of potential predictors involved in
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explaining the patterns of EOL cancer care by rurality could have also biased the results in some of the
studies. Considering the effects of additional infrastructure and healthcare system factors (e.g., hospice
supply, physician supply, referral rates, pharmacotherapy) and lifestyle factors (e.g., support networks)
may provide a more accurate and valid reflection of EOL cancer care and service utilisation.
Many studies only included cohorts with eligibility for fee-for-service Medicare under the
respective national healthcare systems, reducing the generalisability to other populations such as
non-insured populations [16] and those in Health Maintenance Organisation plans. Considering the
types and levels of insurance cover as a confounding factor in future research may also help to uncover
other factors such as financial mechanisms impeding on EOL cancer care treatment patterns [51].
The lack of a standardised approach to defining and measuring rurality also results in difficulty
interpreting comparisons deriving from different geographical based burdens and EOL cancer care
treatment patterns.
4.3. Implications for Practice
While it is evident that rurality plays an important role in the disparities seen in EOL cancer
care provision, it does not mean that rurality necessarily leads to these rural-urban disparities.
The physical barriers associated with rurality may simply be exacerbating the effects of other potential
determinants influencing the availability, accessibility and utilisation patterns of EOL cancer care such
as socioeconomic disadvantage, psychosocial health and transport options. Programs to improve the
provision of EOL cancer care across urban and rural settings that are multidisciplinary in nature will be
most effective as more risk determinants can be addressed. Further research is needed to understand
these determinates of selective EOL treatments to improve rural health outcomes and ensure quality
palliative care is provided to all EOL cancer patients irrespective of geographical location.
4.4. Implications for Science
A growing body of literature and previous reviews suggest that the use of palliative care is associated
with improved quality of life and a reduced likelihood of aggressive care [9,21]. In interpreting the
results of this review, reconsidering the use of acute-care services such as ED visits as a marker of
inappropriate or life-sustaining care when thinking about rural contexts may be required. The finding
regarding rurality to be a strong predictor of disproportionately low access and utilisation of palliative
care services [15–18] was not surprising as noted in past research, the underutilisation of palliative
services in rural areas may be a reflection of the limited availability of hospice services [52] or slower
dissemination of palliative care services or advances [1] to rural communities. As highlighted in a
study demonstrating the major role of location and supply of hospices play in hospice utilisation rates
in rural areas [32], patients may be presenting to an ED and utilising acute hospitals as a substitute
for non-existent palliative care services. Interestingly, Craigs et al. [53] found that patients were less
likely to receive palliative care if they had not received an opioid prescription or anti-cancer treatment.
Given that the results of this systematic review could not support such a finding, rather than looking at
acute-care services or provision of palliative care services, examining receipt of pharmacotherapy and
other process measures may help to further evaluate the quality of EOL cancer care and determine the
extent of the true disparity in EOL cancer care across urban and rural settings.
4.5. Future Research Directions
To better understand the barriers to EOL cancer care service availability, access and usage to
achieve optimal palliative care for all patient populations across the urban-rural continuum, further
research is needed to calculate the percentage of ED visits and hospital admissions across urban and
rural settings that are for palliative care reasons. This could be achieved by looking at discharges from
hospice to inpatient setting or hospital admissions coded as inpatient palliative care.
Studies need to employ reliable and valid quantitative methodologies that link pre-existing
secondary health data to area-level specific geographical classification data using logistic and multilevel
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regression analysis techniques. There appears a clear need for a systematic approach to further explore
pathways linking geographical factors. Adjusting for infrastructure factors such as hospice availability
and referral rates as well as individual level factors such as age, gender, cancer characteristics and SES
may help to uncover important determinants to EOL cancer care service use outcomes. Rather than
relying on variable geographical measurements of rurality that do not account for country to country
differences, including measurements of distance and travel time to the nearest cancer centre or hospice
may also help to improve the reliability and validity of future studies.
5. Conclusions
Overall, the current evidence suggests rurality is an important predictor for poorer outcomes in
the provision of EOL cancer care, especially with the use of services involving palliative care intent.
This review highlights the potential of addressing barriers brought by geographical remoteness has
in reducing EOL cancer care disparities across urban and rural settings. The data show rurality to
be associated with an overreliance on EOL acute-care services and underutilisation of services with
palliative care intent. These results highlight the influence rurality has on the patterns of EOL cancer
care service utilisation that varied significantly based on the intent of the provided care. Further studies
focused on developing a more thorough understanding of the pathways involved in the influence of
geographical barriers on EOL cancer care would be useful to help to inform the development of health
policies to improve supply, access and utilisation of EOL cancer care services. Thus, responding to the
ongoing challenge to provide consistent and reliable access to appropriate and quality EOL cancer care
across urban and rural settings.
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